The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods
Open accessAbstract
Biocatalysis, using enzymes for organic synthesis, has emerged as powerful tool for the synthesis of active pharmaceutical ingredients (APIs). The first industrial biocatalytic processes launched in the first half of the last century exploited whole-cell microorganisms where the specific enzyme at work was not known. In the meantime, novel molecular biology methods, such as efficient gene sequencing and synthesis, triggered breakthroughs in directed evolution for the rapid development of process-stable enzymes with broad substrate scope and good selectivities tailored for specific substrates. To date, enzymes are employed to enable shorter, more efficient, and more sustainable alternative routes toward (established) small molecule APIs, and are additionally used to perform standard reactions in API synthesis more efficiently. Herein, large-scale synthetic routes containing biocatalytic key steps toward >130 APIs of approved drugs and drug candidates are compared with the corresponding chemical protocols (if available) regarding the steps, reaction conditions, and scale. The review is structured according to the functional group formed in the reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–284 of 284
Biocatalysis: Synthesis of Chiral Intermediates for Pharmaceuticals
Patel, R. (2006) · Current Organic Chemistry · doi:10.2174/138527206777698011 · Cited by 71
Synthesizing Chiral Drug Intermediates by Biocatalysis
Jiang, W., & Fang, B. (2020) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-020-03272-3 · Cited by 71
Petersen, M., & Kiener, A. (1999) · Green Chemistry · doi:10.1039/a809538h · Cited by 70
McLaughlin, M., Kong, J., Belyk, K. M., Chen, B., Gibson, A. W., Keen, S. P., Lieberman, D., Milczek, E. M., Moore, J. C., Murray, D., et al. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b00091 · Cited by 69
Purification and Cloning of a Ketoreductase used for the Preparation of Chiral Alcohols
Hanson, R. L., Goldberg, S., Goswami, A., Tully, T. P., & Patel, R. N. (2005) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200505045 · Cited by 65
The never ending success story of tranexamic acid in acquired bleeding
Franchini, M., & Mannucci, P. M. (2020) · Haematologica · doi:10.3324/haematol.2020.250720 · Cited by 62
Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs
Hoyos, P., Pace, V., & Alcántara, A. R. (2019) · Catalysts · doi:10.3390/catal9030260 · Cited by 61
A concise route to MK-4482 (EIDD-2801) from cytidine
Vasudevan, N., Ahlqvist, G. P., McGeough, C. P., Paymode, D. J., Cardoso, F. S. P., Lucas, T., Dietz, J.-P., Opatz, T., Jamison, T. F., Gupton, F. B., et al. (2020) · Chemical Communications · doi:10.1039/d0cc05944g · Cited by 59
Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy.
Lecht, S., Haroutiunian, S., Hoffman, A., & Lazarovici, P. (2007) · PubMed Central · Cited by 58
Bridges, K. A., Toniatti, C., Buser, C. A., Liu, H., Buchholz, T. A., & Meyn, R. E. (2014) · Oncotarget · doi:10.18632/oncotarget.2083 · Cited by 58
Continuous Biocatalytic Processes
Rao, N. N., Lütz, S., Würges, K., & Minör, D. (2009) · Organic Process Research & Development · doi:10.1021/op800314f · Cited by 58
Bioconversion of indene to cis (1S,2R) indandiol and trans (1R,2R) indandiol by Rhodococcus species
Chartrain, M. M., Jackey, B. A., Taylor, C., Sandford, V., Gbewonyo, K., Lister, L. M., DiMichele, L. M., Hirsch, C. F., Heimbuch, B. K., Maxwell, C. A., et al. (1998) · Journal of Fermentation and Bioengineering · doi:10.1016/s0922-338x(99)80005-1 · Cited by 58
Ošlaj, M., Cluzeau, J., Orkić, D., Kopitar, G., Mrak, P., & Časar, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062250 · Cited by 57
Li, H., Moncecchi, J. R., & Truppo, M. D. (2015) · Organic Process Research & Development · doi:10.1021/op5003215 · Cited by 57
Design and engineering of whole-cell biocatalytic cascades for the valorization of fatty acids
Song, J.-W., Seo, J., Oh, D.-K., Bornscheuer, U. T., & Park, J. (2019) · Catalysis Science & Technology · doi:10.1039/c9cy01802f · Cited by 57
Choy, M., & Lam, S. (2007) · Cardiology in Review · doi:10.1097/crd.0b013e318123f771 · Cited by 55
Huh, J. W., Yokoigawa, K., Esaki, N., & Soda, K. (1992) · Journal of Fermentation and Bioengineering · doi:10.1016/0922-338x(92)90082-6 · Cited by 54
Progress Toward a Large-Scale Synthesis of Molnupiravir (MK-4482, EIDD-2801) from Cytidine
Ahlqvist, G. P., McGeough, C. P., Senanayake, C. H., Armstrong, J. D. I., Yadaw, A., Roy, S., Ahmad, S., Snead, D. R., & Jamison, T. F. (2021) · ACS Omega · doi:10.1021/acsomega.1c00772 · Cited by 54
Suvorexant, a dual orexin receptor antagonist for the management of insomnia.
Bennett, T., Bray, D., & Neville, M. W. (2014) · Europe PMC (PubMed Central) · Cited by 53
Mahmoudian, M., BAINES, B. S., Drake, C. S., Hale, R., Jones, P., Piercey, J. E., Montgomery, D. S., Purvis, I. J., Storer, R., Dawson, M. J., et al. (1993) · Enzyme and Microbial Technology · doi:10.1016/0141-0229(93)90005-m · Cited by 53
Ene Reductase‐Catalysed Synthesis of (R)‐Profen Derivatives
Pietruszka, J., & Schölzel, M. (2012) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201100743 · Cited by 52
Roth, S., Präg, A., Wechsler, C., Marolt, M., Ferlaino, S., Lüdeke, S., Sandon, N., Wetzl, D., Iding, H., Wirz, B., et al. (2017) · ChemBioChem · doi:10.1002/cbic.201700261 · Cited by 52
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
Patel, R. N. (2005) · ChemInform · doi:10.1002/chin.200602234 · Cited by 52
Enzymatic self-sufficient hydride transfer processes
Tassano, E., & Hall, M. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00903a · Cited by 52
Enzymatic Preparation of the Chiral ( S )-Sulfoxide Drug Esomeprazole at Pilot-Scale Levels
Xu, N., Zhu, J., Wu, Y., Zhang, Y., Xia, J., Zhao, Q., Lin, G., Yu, H., & Xu, J. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00115 · Cited by 52
L‐Carnitine. Novel Synthesis and Determination of the Optical Purity
Voeffray, R., Perlberger, J., Tenud, L., & Gosteli, J. (1987) · Helvetica Chimica Acta · doi:10.1002/hlca.19870700811 · Cited by 51
An Overview on the Enhancement of Enantioselectivity and Stability of Microbial Epoxide Hydrolases
Saini, P., & Sareen, D. (2017) · Molecular Biotechnology · doi:10.1007/s12033-017-9996-8 · Cited by 51
An Improved and Scalable Process for the Synthesis of Ezetimibe: An Antihypercholesterolemia Drug
Sasikala, C. V. A., Padi, P. R., Sunkara, V., Ramayya, P., Dubey, P. K., Uppala, V. B. R., & Praveen, C. (2009) · Organic Process Research & Development · doi:10.1021/op900039z · Cited by 50
Patel, R. N., Chu, L. N., & Mueller, R. H. (2003) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2003.07.016 · Cited by 50
Pérez‐Venegas, M., & Juaristi, E. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.09.029 · Cited by 50
Rosche, B., Breuer, M., Hauer, B., & Rogers, P. L. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20082 · Cited by 49
Pregabalin’s abuse potential: a mini review focusing on the pharmacological profile
Papazisis, G., & Tzachanis, D. (2014) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp202118 · Cited by 49
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases
Gallant, M., Beaulieu, C., Berthelette, C., Colucci, J. T., Crackower, M. A., Dalton, C. R., Denis, D., Ducharme, Y., Friesen, R. W., Guay, D., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.015 · Cited by 49
Modukuru, N. K., Sukumaran, J., Collier, S. J., Chan, A. S., Gohel, A. P., Huisman, G. W., Keledjian, R., Narayanaswamy, K., Novick, S. J., Palanivel, S. M., et al. (2014) · Organic Process Research & Development · doi:10.1021/op4003483 · Cited by 49
Hoff, B., Plassmeier, J. K., Blankschien, M. D., Letzel, A., Kourtz, L., Schröder, H., Koch, W., & Zelder, O. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004248 · Cited by 48
Zhang, J., Witholt, B., & Li, Z. (2006) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200505439 · Cited by 45
Gill, I., & Patel, R. N. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.021 · Cited by 44
Preparation of β-hydroxy-α-amino Acid Using Recombinant d -Threonine Aldolase
Goldberg, S. L., Goswami, A., Guo, Z., Chan, Y., Lo, E. T., Lee, A., Truc, V. C., Natalie, K. J., Hang, C., Rossano, L. T., et al. (2015) · Organic Process Research & Development · doi:10.1021/acs.oprd.5b00191 · Cited by 44
Catalytic Asymmetric Cyanation Reactions of Aldehydes and Ketones in Total Synthesis
Zeng, X., Sun, J., Liu, C., Ji, C., & Peng, Y. (2019) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201900015 · Cited by 43
Cofactor F420-Dependent Enzymes: An Under-Explored Resource for Asymmetric Redox Biocatalysis
Shah, M. V., Antoney, J., Kang, S. W., Warden, A. C., Hartley, C. J., Nazem‐Bokaee, H., Jackson, C. J., & Scott, C. S. (2019) · Catalysts · doi:10.3390/catal9100868 · Cited by 42
Gu, X., Zhao, J., Chen, L., Li, Y., Yu, B., Tian, X., Min, Z., Xu, S. X., Gu, H., Sun, J., et al. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00473 · Cited by 42
Hosobuchi, M., Kurosawa, K., & Yoshikawa, H. (1993) · Biotechnology and Bioengineering · doi:10.1002/bit.260420705 · Cited by 41
A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia
Balakumar, P., Mahadevan, N., & Ramanathan, S. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190111165015 · Cited by 41
Comprehensive mass analysis for chemical processes, a case study on l -Dopa manufacture
Li, T., & Li, X. (2014) · Green Chemistry · doi:10.1039/c4gc00565a · Cited by 40
Hayes, S. T., Assaf, G., Checksfield, G., Cheung, C., Critcher, D., Harris, L. J., Howard, R. M., Mathew, S. P., Regius, C. T., Scotney, G., et al. (2011) · Organic Process Research & Development · doi:10.1021/op200181f · Cited by 39
Developments in the synthesis of the antiplatelet and antithrombotic drug (S)‐clopidogrel
Saeed, A., Shahzad, D., Faisal, M., Larik, F. A., El-Seedi, H. R., & Channar, P. A. (2017) · Chirality · doi:10.1002/chir.22742 · Cited by 39
Development of the Enabling Route for Glecaprevir via Ring-Closing Metathesis
Cink, R. D., LUKIN, K. A., Bishop, R. D., Zhao, G., Pelc, M. J., Towne, T. B., Gates, B. D., Ravn, M. M., Hill, D. R., Chen, D., et al. (2019) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00469 · Cited by 39
Synthesis of EFdA via a Diastereoselective Aldol Reaction of a Protected 3-Keto Furanose
Fukuyama, K., Ohrui, H., & Kuwahara, S. (2015) · Organic Letters · doi:10.1021/ol5036535 · Cited by 38
Enzyme engineering for biosynthetic cascades
McIntosh, J. A., & Owens, A. E. (2021) · Current Opinion in Green and Sustainable Chemistry · doi:10.1016/j.cogsc.2021.100448 · Cited by 38
Baumer, B., Claßen, T., Pohl, M., & Pietruszka, J. (2020) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202000058 · Cited by 37
Wong, H., Dockens, R. C., Pajor, L., Yeola, S. N., Grace, J. E., Stark, A. D., Taub, R. A., Yocca, F. D., Zaczek, R. C., & Li, Y. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015768 · Cited by 36
PEDRAGOSA‐MOREAU, S., Flohic, A. L., Thienpondt, V., Lefoulon, F., Petit, A.-M., Ríos‐Lombardía, N., Morís, F., & González‐Sabín, J. (2017) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201601222 · Cited by 36
Jost, E., Kazemi, M., Mrkonjić, V., Himo, F., Winkler, C. K., & Kroutil, W. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c02981 · Cited by 36
Self-citationStructure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine.
Haruyama, H., Kuwano, H., Kinoshita, T., Terahara, A., Nishigaki, T., & Tamura, C. (1986) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.34.1459 · Cited by 35
Arco, J. D., Acosta, J., & Fernández‐Lucas, J. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107701 · Cited by 34
Winkler, C. K., Simić, S., Jurkaš, V., Bierbaumer, S., Schmermund, L., Poschenrieder, S., Berger, S. A., Kulterer, E., Kourist, R., & Kroutil, W. (2021) · ChemPhotoChem · doi:10.1002/cptc.202100109 · Cited by 31
Self-citationHussainy, R. A., Verbeek, J., van der Born, D., Braker, A. H., Leysen, J. E., Knol, R. J. J., Booij, J., & Herscheid, J. D. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1009956 · Cited by 30
Shrestha, N., Nimick, M., Dass, P., Rosengren, R. J., & Ashton, J. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-55376-4 · Cited by 30
Feng, Y., Luo, Z., Sun, G., Chen, M., Lai, J., Wei, L., Goldmann, S., Zhang, L., & Wang, Z. (2017) · Organic Process Research & Development · doi:10.1021/acs.oprd.7b00074 · Cited by 29
You, Z., Liu, Z., & Zheng, Y. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5357-0 · Cited by 28
Zhao, F.-J., Liu, Y., Pei, X.-Q., Guo, C., & Wu, Z. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7947-0 · Cited by 28
Process intensification using immobilized enzymes for the development of white biotechnology
Salvi, H. M., & Yadav, G. D. (2021) · Catalysis Science & Technology · doi:10.1039/d1cy00020a · Cited by 28
Efficient bioreductive production of (S)-N-Boc-3-hydroxypiperidine using ketoreductase ChKRED03
Xu, G.-P., Wang, H.-B., & Wu, Z. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.04.008 · Cited by 26
Biocatalysis in Organic Synthesis: The Retrosynthesis Approach
(2017) · Focus on Catalysts · doi:10.1016/j.focat.2017.12.052 · Cited by 26
Goldberg, S. L., Nanduri, V., Chu, L. N., Johnston, R. M., & Patel, R. N. (2006) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2006.03.033 · Cited by 24
Calow, A. D. J., Fernández, E., & Whiting, A. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01142b · Cited by 23
Nomeir, A. A., Pramanik, B. N., Heimark, L. D., Bennett, F., Veals, J., Bartner, P. L., Hilbert, M., Saksena, A. K., McNamara, P., GIRIJAVALLABHAN, V. M., et al. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1341 · Cited by 21
Regioselective Biocatalytic Transformations Employing Transaminases and Tyrosine Phenol Lyases
Martínez‐Montero, L., Schrittwieser, J. H., & Kroutil, W. (2018) · Topics in Catalysis · doi:10.1007/s11244-018-1054-7 · Cited by 20
Self-citationWienrich, M., Ceci, A., Ensinger, H. A., Gaida, W., Mendla, K. D., Osugi, T., Raschig, A., & Weiser, T. W. (2002) · Drug Development Research · doi:10.1002/ddr.10085 · Cited by 17
Development of a practical biocatalytic process for ( S )- N -Boc-3-hydroxypiperidine synthesis
Chen, L.-F., Fan, H., Zhang, Y., Wu, K., Wang, H., Lin, J., & Wei, D. (2017) · Tetrahedron Letters · doi:10.1016/j.tetlet.2017.03.037 · Cited by 17
Willrodt, C., Gröning, J. A. D., Nerke, P., Koch, R., Scholtissek, A., Heine, T., Schmid, A., Bühler, B., & Tischler, D. (2019) · ChemCatChem · doi:10.1002/cctc.201901894 · Cited by 17
Blakemore, C. A., France, S. P., Samp, L., et al. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00397 · Cited by 17
Fed-batch bioconversion of indene to cis-indandiol
Amanullah, A., Hewitt, C. J., Nienow, A. W., Lee, C., Chartrain, M. M., Buckland, B. C., Drew, S. W., & Woodley, J. M. (2002) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(02)00183-7 · Cited by 16
Artificial Biocatalytic Linear Cascades to Access Hydroxy Acids, Lactones, and α- and β-Amino Acids
Schrittwieser, J. H., Velikogne, S., & Kroutil, W. (2018) · Catalysts · doi:10.3390/catal8050205 · Cited by 16
Self-citationKomlósi, K., Havasi, V., Bene, J., Süle, N., Pajor, L., Nicolai, R., Benatti, P., Calvani, M., & Melegh, B. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.09.042 · Cited by 15
Bioconversion of mevastatin to pravastatin by various microorganisms and its applications – A review
Syed, M. B., & Ponnusamy, T. (2017) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2017.11.002 · Cited by 14
Faber, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-61590-5_2 · Cited by 14
Self-citationSuzuki, T., & Kasai, N. (2003) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.15.329 · Cited by 12
Current and emerging drug treatment strategies for peripheral arterial disease
Essa, H., Torella, F., & Lip, G. Y. H. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1774556 · Cited by 12
Pham, H. T., Yoo, S., & Mésplède, T. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1724281 · Cited by 8
Practical Enzymatic Production of Carbocycles
Wang, W., Taber, D. F., & Renata, H. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202101232 · Cited by 7
Biocatalytic Cascades for API Synthesis
Woodley, J. M. (2016) · doi:10.1002/9781118828083.ch20 · Cited by 6
Pravastatin (Pravachol, Mevalotin)
Hara, Y., & Nagaoka, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8906-1_3 · Cited by 4
9.16 Enzyme Evolution as a Tool for Creating Improved Catalysts for Large-Scale Organic Synthesis
Huisman, G. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-08-097742-3.00925-3 · Cited by 2
Research works printed but not linked: 310
- 10.2307/2168396 · doi:10.2307/2168396
- Neidleman S. L., 2001, Applied Biocatalysis in Specialty Chemicals and Pharmaceuticals, 14, 10.1021/bk-2001-0776.ch002 · doi:10.1021/bk-2001-0776.ch002
- Neuberg C., 1921, Biochem. Z., 115, 282
- Hildebrandt G., 1930, Verfahren Zur Herstellung Von 1-1-Phenyl-2-Methylaminopropan-1-Ol, DE548459C
- Tramper J., 2001, Synthesis of B-Lactam Antibiotics, 206, 10.1007/978-94-010-0850-1_5 · doi:10.1007/978-94-010-0850-1_5
- Klaus, B.; Volker, K.; Bornscheuer, U. T.Biocatalysts and Enzyme Technology; Wiley-VCH: Weinheim, 2005; pp 521–539.
- 10.1021/ja01127a531 · doi:10.1021/ja01127a531
- 10.1021/ja01135a528 · doi:10.1021/ja01135a528
- Faber Fessner Turner.Biocatalysis in Organic Synthesis 1–3; Thieme: Stuttgart, New York, Delhi, Rio, 2015; pp 1–543. · doi:10.1055/b-003-125815
- Arroyo M., 2017, Biocatalysis for Industrial Production of Active Pharmaceutical Ingredients (APIs), 10.1016/B978-0-12-803725-6.00017-0 · doi:10.1016/b978-0-12-803725-6.00017-0
- 10.2174/092986712804485683 · doi:10.2174/092986712804485683
- 10.1016/j.cbpa.2013.01.017 · doi:10.1016/j.cbpa.2013.01.017
- 10.1016/j.copbio.2016.04.023 · doi:10.1016/j.copbio.2016.04.023
- Patel R. N., 2004, Food Technol. Biotechnol., 42, 305
- 10.1016/j.ddtec.2012.08.002 · doi:10.1016/j.ddtec.2012.08.002
- Sutton P. W., 2012, Practical Methods for Biocatalysis and Biotransformations 2, 1
- Patel R. N., 2016, Applications of Biocatalysis for Pharmaceuticals and Chemicals, 10.1016/B978-0-12-411518-7.00011-1 · doi:10.1016/b978-0-12-411518-7.00011-1
- Liese A., 2006, Industrial Biotransformations, 2, 147, 10.1002/9783527608188.ch6a · doi:10.1002/9783527608188.ch6a
- Patel R. N., 2016, Green Biocatalysis, 71, 10.1002/9781118828083.ch4 · doi:10.1002/9781118828083.ch4
- 10.1002/anie.202001876 · doi:10.1002/anie.202001876
- 10.1007/s00253-007-1002-0 · doi:10.1007/s00253-007-1002-0
- 10.1007/s00253-016-8083-6 · doi:10.1007/s00253-016-8083-6
- 10.1016/j.ccr.2017.08.008 · doi:10.1016/j.ccr.2017.08.008
- 10.1351/pac196409010119 · doi:10.1351/pac196409010119
- 10.1021/op900272d · doi:10.1021/op900272d
- 10.1016/j.bcab.2016.07.001 · doi:10.1016/j.bcab.2016.07.001
- 10.1021/bi7002444 · doi:10.1021/bi7002444
- 10.1002/adsc.201701282 · doi:10.1002/adsc.201701282
- 10.1002/adsc.201100384 · doi:10.1002/adsc.201100384
- 10.1016/j.biotechadv.2020.107615 · doi:10.1016/j.biotechadv.2020.107615
- 10.1038/s41929-020-00507-8 · doi:10.1038/s41929-020-00507-8
- 10.1016/j.tet.2015.12.061 · doi:10.1016/j.tet.2015.12.061
- 10.1128/aem.63.5.1974-1979.1997 · doi:10.1128/aem.63.5.1974-1979.1997
- 10.1007/BF02932009 · doi:10.1007/bf02932009
- 10.1016/j.tetasy.2010.11.013 · doi:10.1016/j.tetasy.2010.11.013
- 10.1007/s00706-005-0330-y · doi:10.1007/s00706-005-0330-y
- 10.1016/0168-1656(92)90136-W · doi:10.1016/0168-1656(92)90136-w
- 10.1002/anie.201901462 · doi:10.1002/anie.201901462
- 10.1021/acscatal.6b00758 · doi:10.1021/acscatal.6b00758
- 10.1016/j.cogsc.2021.100476 · doi:10.1016/j.cogsc.2021.100476
- 10.1021/jacs.0c09994 · doi:10.1021/jacs.0c09994
- 10.1016/j.cbpa.2009.11.029 · doi:10.1016/j.cbpa.2009.11.029
- 10.1073/pnas.0307563101 · doi:10.1073/pnas.0307563101
- 10.1111/j.1749-6632.1995.tb19969.x · doi:10.1111/j.1749-6632.1995.tb19969.x
- 10.1016/j.cbpa.2013.02.017 · doi:10.1016/j.cbpa.2013.02.017
- 10.1002/ejoc.201600228 · doi:10.1002/ejoc.201600228
- 10.1039/C6OB00934D · doi:10.1039/c6ob00934d
- 10.2174/18722083113076660010 · doi:10.2174/18722083113076660010
- 10.1021/jo00066a027 · doi:10.1021/jo00066a027
- 10.1021/acs.joc.5b00197 · doi:10.1021/acs.joc.5b00197
- 10.1021/cr0406918 · doi:10.1021/cr0406918
- 10.1021/jo400807c · doi:10.1021/jo400807c
- Mundorff E., 2010, Ketoreductase Polypeptides for the Stereoselective Production of (4s)-3-[(5s)-5-(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One, 025085 A2
- 10.1002/btpr.3068 · doi:10.1002/btpr.3068
- 10.1016/j.biortech.2016.12.098 · doi:10.1016/j.biortech.2016.12.098
- 10.1021/jo990428k · doi:10.1021/jo990428k
- 10.1021/jo2010846 · doi:10.1021/jo2010846
- 10.1016/j.bmcl.2006.09.078 · doi:10.1016/j.bmcl.2006.09.078
- 10.1016/j.tetlet.2013.03.089 · doi:10.1016/j.tetlet.2013.03.089
- 10.1021/op300034u · doi:10.1021/op300034u
- 10.1016/j.tetasy.2016.09.007 · doi:10.1016/j.tetasy.2016.09.007
- Pitsikas N., 2000, Curr. Opin. Invest. Drugs, 1, 116
- Fuller R. W., 1994, J. Pharmacol. Exp. Ther., 269, 132
- 10.1016/j.cclet.2007.10.046 · doi:10.1016/j.cclet.2007.10.046
- 10.1002/adsc.201300849 · doi:10.1002/adsc.201300849
- 10.1021/ja200250p · doi:10.1021/ja200250p
- 10.1021/acs.oprd.7b00230 · doi:10.1021/acs.oprd.7b00230
- 10.1016/j.tetlet.2012.06.097 · doi:10.1016/j.tetlet.2012.06.097
- 10.1002/adsc.201100366 · doi:10.1002/adsc.201100366
- 10.1016/j.jorganchem.2009.02.008 · doi:10.1016/j.jorganchem.2009.02.008
- 10.1016/j.tetasy.2006.01.039 · doi:10.1016/j.tetasy.2006.01.039
- 10.1186/s40643-015-0040-1 · doi:10.1186/s40643-015-0040-1
- 10.1016/j.jbiotec.2013.09.021 · doi:10.1016/j.jbiotec.2013.09.021
- 10.1016/j.bej.2014.07.008 · doi:10.1016/j.bej.2014.07.008
- 10.1021/jo035794p · doi:10.1021/jo035794p
- 10.1021/acs.oprd.7b00096 · doi:10.1021/acs.oprd.7b00096
- 10.1016/j.clinthera.2006.09.017 · DOI
- Cazzola M., 2009, Curr. Opin. Invest. Drugs, 10, 482
- 10.1021/ol402269k · doi:10.1021/ol402269k
- 10.1021/acs.oprd.9b00004 · doi:10.1021/acs.oprd.9b00004
- 10.1016/S0957-4166(03)00363-X · doi:10.1016/s0957-4166(03)00363-x
- 10.1021/ol101200z · doi:10.1021/ol101200z
- 10.1021/jo00042a010 · doi:10.1021/jo00042a010
- 10.1021/op9002714 · doi:10.1021/op9002714
- Parmar S., 2014, Pharm. Ther., 39, 483
- 10.1021/op500022y · doi:10.1021/op500022y
- 10.1021/acs.oprd.8b00232 · doi:10.1021/acs.oprd.8b00232
- 10.1021/op700255b · doi:10.1021/op700255b
- 10.2147/TCRM.S3114 · doi:10.2147/tcrm.s3114
- 10.2147/PGPM.S52715 · doi:10.2147/pgpm.s52715
- 10.1002/anie.200460852 · doi:10.1002/anie.200460852
- 10.1016/0960-0760(91)90129-S · doi:10.1016/0960-0760(91)90129-s
- 10.1002/ejoc.201501557 · doi:10.1002/ejoc.201501557
- 10.1039/C0CC04585C · doi:10.1039/c0cc04585c
- 10.1002/cctc.201300841 · doi:10.1002/cctc.201300841
- 10.1016/S0968-0896(99)00102-9 · doi:10.1016/s0968-0896(99)00102-9
- 10.1002/ejoc.201301429 · doi:10.1002/ejoc.201301429
- 10.1016/j.tetasy.2005.12.025 · doi:10.1016/j.tetasy.2005.12.025
- 10.1111/j.1749-6632.1995.tb19946.x · doi:10.1111/j.1749-6632.1995.tb19946.x
- 10.1016/S0957-4166(02)00010-1 · doi:10.1016/s0957-4166(02)00010-1
- 10.1002/adsc.201900871 · doi:10.1002/adsc.201900871
- 10.1002/anie.200703296 · doi:10.1002/anie.200703296
- 10.1016/0039-128X(92)90013-Y · doi:10.1016/0039-128x(92)90013-y
- 10.1038/162619a0 · doi:10.1038/162619a0
- 10.1021/ja01143a033 · doi:10.1021/ja01143a033
- 10.1021/ja01621a092 · doi:10.1021/ja01621a092
- 10.1021/ja01621a093 · doi:10.1021/ja01621a093
- Serizawa N., 1996, Biotechnology Annual Review, 2, 373, 10.1016/S1387-2656(08)70017-6 · doi:10.1016/s1387-2656(08)70017-6
- 10.1016/0005-2760(91)90052-J · doi:10.1016/0005-2760(91)90052-j
- 10.1023/A:1026281914301 · doi:10.1023/a:1026281914301
- 10.1021/op020028q · doi:10.1021/op020028q
- 10.1016/j.cbpa.2018.11.011 · doi:10.1016/j.cbpa.2018.11.011
- 10.1021/acs.oprd.5b00282 · doi:10.1021/acs.oprd.5b00282
- 10.1016/j.enzmictec.2009.08.006 · doi:10.1016/j.enzmictec.2009.08.006
- Reider P. J., 1997, Chimia, 51, 306, 10.2533/chimia.1997.306 · doi:10.2533/chimia.1997.306
- 10.1016/0040-4039(95)00696-A · doi:10.1016/0040-4039(95)00696-a
- 10.1006/mben.1998.0107 · doi:10.1006/mben.1998.0107
- 10.1038/sj.jim.2900402 · doi:10.1038/sj.jim.2900402
- 10.1002/bit.10479 · DOI
- 10.1016/0968-0896(94)80024-3 · doi:10.1016/0968-0896(94)80024-3
- 10.1002/adsc.200900844 · doi:10.1002/adsc.200900844
- 10.1002/anie.200901345 · doi:10.1002/anie.200901345
- 10.1021/op020013s · doi:10.1021/op020013s
- 10.1021/jo2018872 · doi:10.1021/jo2018872
- 10.1016/j.apcata.2014.12.015 · doi:10.1016/j.apcata.2014.12.015
- 10.1007/BF00169419 · doi:10.1007/bf00169419
- 10.1021/op700160a · doi:10.1021/op700160a
- 10.1021/op100254z · doi:10.1021/op100254z
- 10.1021/jo9809229 · doi:10.1021/jo9809229
- 10.1021/op900163a · doi:10.1021/op900163a
- 10.1016/0040-4039(95)00143-Z · doi:10.1016/0040-4039(95)00143-z
- 10.1016/0040-4039(96)01203-8 · doi:10.1016/0040-4039(96)01203-8
- 10.1016/S1359-6446(97)01078-7 · doi:10.1016/s1359-6446(97)01078-7
- 10.1021/op2002497 · doi:10.1021/op2002497
- 10.1016/0167-7799(88)90057-1 · doi:10.1016/0167-7799(88)90057-1
- Grunwald, P.Industrial Biocatalysis; CRC Press, 2014; pp 1–1196. · doi:10.1201/b17828
- Leuenberger H. G. W., 1999, Chimia, 53, 536, 10.2533/chimia.1999.536 · doi:10.2533/chimia.1999.536
- 10.1039/p19920000589 · doi:10.1039/p19920000589
- 10.1039/P19930000313 · doi:10.1039/p19930000313
- 10.1016/0968-0896(94)80005-7 · doi:10.1016/0968-0896(94)80005-7
- 10.1021/acs.oprd.5b00057 · doi:10.1021/acs.oprd.5b00057
- 10.1002/1615-4169(200108)343:6/7<527::AID-ADSC527>3.0.CO;2-I · doi:10.1002/1615-4169(200108)343:6/7<527::aid-adsc527>3.0.co;2-i
- 10.1016/j.bmc.2015.02.011 · DOI
- 10.1016/j.tet.2003.10.119 · doi:10.1016/j.tet.2003.10.119
- 10.1007/s00253-020-10694-w · doi:10.1007/s00253-020-10694-w
- 10.1007/s00253-021-11266-2 · doi:10.1007/s00253-021-11266-2
- 10.1007/s00253-012-4523-0 · doi:10.1007/s00253-012-4523-0
- 10.1016/S0168-1656(00)00220-0 · doi:10.1016/s0168-1656(00)00220-0
- 10.1093/ndt/gfl356 · doi:10.1093/ndt/gfl356
- 10.1021/ja00097a082 · doi:10.1021/ja00097a082
- 10.1016/j.ces.2020.116312 · doi:10.1016/j.ces.2020.116312
- 10.1007/s00253-018-9392-8 · doi:10.1007/s00253-018-9392-8
- 10.1016/S0968-0896(02)00429-7 · doi:10.1016/s0968-0896(02)00429-7
- 10.1055/s-1991-26522 · doi:10.1055/s-1991-26522
- 10.4052/tigg.16.143 · doi:10.4052/tigg.16.143
- 10.1021/acs.oprd.5b00192 · doi:10.1021/acs.oprd.5b00192
- 10.1016/S0922-338X(97)81900-9 · doi:10.1016/s0922-338x(97)81900-9
- 10.1002/bit.1122 · doi:10.1002/bit.1122
- 10.1002/bit.20513 · doi:10.1002/bit.20513
- 10.1007/s10529-007-9525-0 · doi:10.1007/s10529-007-9525-0
- Poechlauer P., 2004, Asymmetric Catalysis on Industrial Scale: Challenges, Approaches and Solutions, 1, 149
- 10.1110/ps.38102 · doi:10.1110/ps.38102
- 10.1016/j.molcatb.2003.10.006 · doi:10.1016/j.molcatb.2003.10.006
- 10.1006/prep.1997.0765 · doi:10.1006/prep.1997.0765
- 10.1016/j.jbiotec.2006.12.009 · doi:10.1016/j.jbiotec.2006.12.009
- 10.1002/bit.10317 · doi:10.1002/bit.10317
- 10.1021/op050264b · doi:10.1021/op050264b
- 10.1002/anie.200500435 · doi:10.1002/anie.200500435
- 10.1002/anie.200352141 · doi:10.1002/anie.200352141
- 10.1021/op4000237 · doi:10.1021/op4000237
- 10.1002/ejoc.201500852 · doi:10.1002/ejoc.201500852
- 10.1002/adsc.201700356 · doi:10.1002/adsc.201700356
- 10.1016/j.cbpa.2016.11.022 · doi:10.1016/j.cbpa.2016.11.022
- 10.1039/b105464n · doi:10.1039/b105464n
- 10.1021/cr020029g · doi:10.1021/cr020029g
- 10.1039/B405651E · doi:10.1039/b405651e
- Reetz M. T., 1996, Chimia, 50, 668, 10.2533/chimia.1996.668 · doi:10.2533/chimia.1996.668
- 10.1016/S0958-1669(99)00042-7 · doi:10.1016/s0958-1669(99)00042-7
- 10.1021/acs.oprd.7b00235 · DOI
- 10.1021/op400233z · doi:10.1021/op400233z
- 10.1016/j.tetlet.2011.11.029 · doi:10.1016/j.tetlet.2011.11.029
- 10.1021/acs.oprd.0c00557 · doi:10.1021/acs.oprd.0c00557
- Bennett T., 2014, Pharm. Ther., 39, 264
- 10.1021/ja202358f · doi:10.1021/ja202358f
- 10.1021/jo202620r · doi:10.1021/jo202620r
- 10.1021/ol403630g · doi:10.1021/ol403630g
- 10.1038/nrd3323 · doi:10.1038/nrd3323
- 10.1021/ol501002a · doi:10.1021/ol501002a
- 10.1021/op400133d · doi:10.1021/op400133d
- 10.1021/op400131h · doi:10.1021/op400131h
- 10.1007/s10529-009-0057-7 · doi:10.1007/s10529-009-0057-7
- 10.1128/AAC.00418-09 · doi:10.1128/aac.00418-09
- 10.1002/adsc.201100558 · doi:10.1002/adsc.201100558
- 10.1093/protein/gzs065 · doi:10.1093/protein/gzs065
- 10.1002/adsc.201300993 · doi:10.1002/adsc.201300993
- 10.1039/c0cc00585a · doi:10.1039/c0cc00585a
- 10.1016/j.tetasy.2013.12.012 · doi:10.1016/j.tetasy.2013.12.012
- 10.1016/j.molcatb.2009.05.006 · doi:10.1016/j.molcatb.2009.05.006
- 10.1002/adsc.202000870 · doi:10.1002/adsc.202000870
- 10.1021/acscatal.8b02924 · doi:10.1021/acscatal.8b02924
200 of 310 shown
Cited by
Photobiocatalytic Strategies for Organic Synthesis
Emmanuel, M. A., Bender, S. G., Bilodeau, C., Carceller, J. M., DeHovitz, J. S., Fu, H., Liu, Y., Nicholls, B. T., Ouyang, Y., Page, C. G., et al. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00767 · Cited by 328
Enzymatic Conversion of CO2: From Natural to Artificial Utilization
Bierbaumer, S., Nattermann, M., Schulz, L., Zschoche, R., Erb, T. J., Winkler, C. K., Tinzl, M., & Glueck, S. M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00581 · Cited by 279
Self-citation
Metadata
- Authors
- Simić, S., Zukić, E., Schmermund, L., Faber, K., Winkler, C. K., & Kroutil, W.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-11-30
- Volume
- 122
- Issue
- 1
- Pages
- 1052-1126
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W3214882609
- Cited by
- 264
- References
- 284
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- European Commission (No. 764920 (PhotoBioCat), No. 862081 (CLASSY))
- ??sterreichische Forschungsf??rderungsgesellschaft
- Bundesministeriums f??r Kunst, Kultur, ??ffentlichen Dienst und Sport
- Bundesministerium f??r Digitalisierung und Wirtschaftsstandort
- Austrian Centre of Industrial Biotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.